GSE160176
Study the differential gene expression of C57/BL6 Mouse tumors treated with EZH2 inhibitor GSK343 II
The study evaluated the differential gene expression in control Antibody or Ant-CXCL10 antibody injected mouse when compared to EZH2 inhibitor GSK343 treated mice tumors Briefly, control Antibody or Ant-CXCL10 antibody injected C57BL/6 mouse were treated with or without GSK343were analyzed for RNA-seq Overall design: Total RNA was extracted from C57/BL6 mouse tumors, followed by poly-A selection and RNA-sequencing using Illumina Hi-Seq 2500 platform, with three biological replicates for each transformed sample.